Abstract 2924: Preclinical analysis of synergistic antitumor effect of eribulin and HDAC inhibitor for triple-negative breast cancer cells
2014 ◽
2017 ◽
Vol 24
(11)
◽
pp. 1356-1367.e8
◽
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
Vol 34
◽
pp. 102383